Browse diseases

…ospective, single-arm study enrolling patients (≥18 years) with severe asthma, newly prescribed mepolizumab (100 mg subcutaneously). Changes …

… in relation to type 2 biomarkers in patients with uncontrolled severe asthma.Methods We reviewed our severe asthma MDT identifying 38 patien…

…There is a need for other management options in obesity related severe asthma.…

…een vaping, vaping exposure and asthma control. The majority of severe asthma patients reported worse asthma symptoms after second-hand vape …

…5. It effectively reduces steroid use and exacerbations in some severe asthma patients but approximately one third of treated patients do not…

…Background Biologic therapies have transformed severe asthma care, but the real-world evolution of multidimensional clinical…

…s following biologic initiationConclusions Biologic therapy for pwSA significantly reduces total, non-SABA medication-related, and h…

…rvational, prospective study enrolled patients (≥18 years) with severe asthma, newly prescribed mepolizumab (100-mg subcutaneously). Changes …

…Severe asthma is now regarded as ‘too-late’ asthma, reflecting missed opportu…

… there is compelling evidence to show azithromycin is useful in cystic fibrosis,2 3 primary ciliary dyskinesia4 and severe asthma.5 Despite a p…

…e to interscalene brachial plexus block for patients with known pulmonary pathology undergoing shoulder surgery.2–5 Consequently, protection of the…

…ered statistical significance.Results Thirty-four patients with SA treated with tezepelumab were included; 81.2% women, 52 years (…